Be aware of multi-level lists

Users on the internet scan for information. Pages with multi-level lists can be daunting and can make pages harder to scan. So consider some alternatives when it makes sense. Below is a multi-level list followed by two alternative ways to format the same content.

Multi-level list

• Chemotherapy
  • Epirubicin concomitant with cyclophosphamide followed by
  • Docetaxel or Paclitaxel
• Endocrine therapy (adjuvant hormone therapy)
  • Tamoxifen
  • Aromatase inhibitors
• Targeted therapy
  • Trastuzumab (Herceptin)
• Radiotherapy

Alternative 1

• Chemotherapy: Epirubicin concomitant with cyclophosphamide followed by Docetaxel or Paclitaxel
• Endocrine therapy (adjuvant hormone therapy): Tamoxifen, Aromatase inhibitors
• Targeted therapy: Trastuzumab (Herceptin)
• Radiotherapy

Alternative 2

Chemotherapy	Epirubicin concomitant with cyclophosphamide followed by Docetaxel or Paclitaxel
Endocrine therapy (adjuvant hormone therapy)	Tamoxifen Aromatase inhibitors
Targeted therapy	Trastuzumab (Herceptin)
Radiotherapy